Skip to main content
Saulius Girnius, MD, Hematology, Cincinnati, OH, Bethesda North Hospital

SauliusKazimieraGirniusMD

Hematology Cincinnati, OH

Hematologic Oncology

Physician

Dr. Girnius is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Girnius' full profile

Already have an account?

  • Office

    Hoxworth Blood Center
    3130 Highland Avenue, 3rd Floor, ML0562
    Cincinnati, OH 45219
    Phone+1 513-584-4268
    Fax+1 513-558-2124
  • Is this information wrong?

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 2006
  • University of Michigan-Ann Arbor
    University of Michigan-Ann ArborBS, Cellular and Molecular Biology, 1998 - 2001

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2025
  • MA State Medical License
    MA State Medical License 2008 - 2013
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Travel Award Amyloid Foundation, 2010
  • Travel Award ASH, 2007
  • Simon Pendleton Kramer Research Award 2006

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients with AL Amyloidosis and Cardiac Involvement  
    Girnius S, Seldin DS, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V, Bone Marrow Transplant, 12/9/2013
  • Overview of Systemic and Localized Amyloidosis  
    Girnius S, Reviews in Healthcare, 10/2013
  • New Hematologic Response Criteria Predict Survival In Patients With Immunoglobulin Light Chain Amyloidosis Treated With High-Dose Melphalan And Autologous Stem Cell Tr...  
    Girnius S, Seldin DC, Cibeira, M, and Sanchorawala V, J Clin Oncol, 7/1/2013
  • Join now to see all

Professional Memberships

Hospital Affiliations